Literature DB >> 2211372

Synthesis and biological activity of some amide derivatives of the lantibiotic actagardine.

A Malabarba1, R Pallanza, M Berti, B Cavalleri.   

Abstract

A series of basic carboxamides of actagardine (1), a lantibiotic possessing good antistreptococcal activity, were synthetized. Some physico-chemical characteristics, in particular charge and lipophilicity, that influence water solubility were determined. The in vitro and in vivo activity was evaluated. The monocarboxamides were generally more active than actagardine against selected Gram-positive bacteria. The 3,3-dimethylamino-1-propylamide hydrochloride (4) showed good water solubility, bactericidal action and favourable antibacterial activity and it appears to be a suitable drug for further investigation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211372     DOI: 10.7164/antibiotics.43.1089

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

Review 1.  New horizons for host defense peptides and lantibiotics.

Authors:  Michael John Dawson; Richard W Scott
Journal:  Curr Opin Pharmacol       Date:  2012-07-07       Impact factor: 5.547

Review 2.  Advancing cell wall inhibitors towards clinical applications.

Authors:  Sonia I Maffioli; João C S Cruz; Paolo Monciardini; Margherita Sosio; Stefano Donadio
Journal:  J Ind Microbiol Biotechnol       Date:  2015-10-29       Impact factor: 3.346

3.  The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.

Authors:  H Brötz; G Bierbaum; K Leopold; P E Reynolds; H G Sahl
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

4.  Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin.

Authors:  Christiane Szekat; Ralph W Jack; Dirk Skutlarek; Harald Färber; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

5.  Antibacterial activity of the novel semisynthetic lantibiotic NVB333 in vitro and in experimental infection models.

Authors:  Steven Boakes; William J Weiss; Mary Vinson; Sjoerd Wadman; Michael J Dawson
Journal:  J Antibiot (Tokyo)       Date:  2016-05-18       Impact factor: 2.649

Review 6.  Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings.

Authors:  Anton Du Preez van Staden; Winschau F van Zyl; Marla Trindade; Leon M T Dicks; Carine Smith
Journal:  Appl Environ Microbiol       Date:  2021-06-25       Impact factor: 4.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.